Good morning everyone:
Well, your seven-day trial period for 2021 is now over. Anyone want to return it? Needless to say, it's been a hard week and most everything in this week's roundup seems so minuscule when compared to the national events that have dominated the headlines. We won't prattle on given the seriousness of everything that's occurred in the last week. We hope the new year finds everyone safe and healthy. We hope it stays that way as we embark on a new legislative session. Now onto the the significant stories we published last . . .